During the past decade, UMHAT "Prof.Dr. Stoyan Kirkovich" conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMHAT "Prof.Dr. Stoyan Kirkovich"" #1 sponsor was "Pfizer" with 3 trials, followed by "Agios Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Instituto Grifols, S.A." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT "Prof.Dr. Stoyan Kirkovich"" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UMHAT "Prof.Dr. Stoyan Kirkovich"" are "Chronic Lymphocytic Leukemia" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Excessive Bleeding During Surgery" (1 trials), "Hemophilia A" (1 trials) and "Hemophilia B" (1 trials). Many other conditions were trialed in "UMHAT "Prof.Dr. Stoyan Kirkovich"" in a lesser frequency.

Most popular intervention types in "UMHAT "Prof.Dr. Stoyan Kirkovich"" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mitapivat" (2 trials), "Placebo" (2 trials), "Placebo Matching Mitapivat" (2 trials), "BI 690517" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT "Prof.Dr. Stoyan Kirkovich"" are 8 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "UMHAT "Prof.Dr. Stoyan Kirkovich"". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UMHAT "Prof.Dr. Stoyan Kirkovich", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT "Prof.Dr. Stoyan Kirkovich", 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".